Confounding effects of metformin on the human gut microbiome in Type 2 diabetes
Övrig text i vetenskaplig tidskrift, 2016
Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.
Författare
Adil Mardinoglu
Kungliga Tekniska Högskolan (KTH)
Chalmers, Biologi och bioteknik, Systembiologi
Jan Borén
Göteborgs universitet
Ulf Smith
Göteborgs universitet
Sahlgrenska universitetssjukhuset
Cell Metabolism
1550-4131 (ISSN) 19327420 (eISSN)
Vol. 23 1 10-12Ämneskategorier
Cell- och molekylärbiologi
DOI
10.1016/j.cmet.2015.12.012